Jiangsu gdk Biotechnology Co., Ltd. (688670.SS)
CNY 14.38
(0.0%)
CNY 14.38
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 64.05 Million CNY | 52.37% |
| 2022 | 42.04 Million CNY | 319.97% |
| 2021 | 10.01 Million CNY | -96.63% |
| 2020 | 296.74 Million CNY | 421.42% |
| 2019 | 56.91 Million CNY | 89.7% |
| 2018 | 30 Million CNY | 0.0% |
| 2017 | 30 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 59.64 Million CNY | 4.27% |
| 2024 Q1 | 68.05 Million CNY | 6.24% |
| 2024 Q2 | 57.2 Million CNY | -15.95% |
| 2023 Q3 | 71.05 Million CNY | 1.73% |
| 2023 FY | 64.05 Million CNY | 52.37% |
| 2023 Q4 | 64.05 Million CNY | -9.85% |
| 2023 Q2 | 69.85 Million CNY | 42.42% |
| 2023 Q1 | 49.04 Million CNY | 16.66% |
| 2022 Q3 | 57.05 Million CNY | 58.32% |
| 2022 Q2 | 36.03 Million CNY | 79.98% |
| 2022 Q1 | 20.02 Million CNY | 100.0% |
| 2022 FY | 42.04 Million CNY | 319.97% |
| 2022 Q4 | 42.04 Million CNY | -26.31% |
| 2021 FY | 10.01 Million CNY | -96.63% |
| 2021 Q1 | 373.59 Million CNY | 25.9% |
| 2021 Q4 | 10.01 Million CNY | 0.0% |
| 2021 Q3 | - CNY | -100.0% |
| 2021 Q2 | 417.29 Million CNY | 11.7% |
| 2020 FY | 296.74 Million CNY | 421.42% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 Q4 | 296.74 Million CNY | 0.0% |
| 2020 Q2 | 236.65 Million CNY | 0.0% |
| 2019 FY | 56.91 Million CNY | 89.7% |
| 2018 FY | 30 Million CNY | 0.0% |
| 2017 FY | 30 Million CNY | 0.0% |